Key result
Endothelin-1 and vein vasoactivity drive retinal vein occlusion pathogenesis alongside practical management strategies.
Answers are grounded in this paper and cite their sources.
Retinal vein occlusion (RVO) is a common vascular disease of retina; however, the pathomechanism leading to RVO is not yet clear. In general, increasing age, hypertension, arteriosclerosis, diabetes mellitus, dyslipidemia, cardiovascular disorder, and cerebral stroke are systemic risk factors of RVO. However, RVO often occur in the unilateral eye and sometimes develop in young subjects who have no arteriosclerosis. In addition, RVO show different variations on the degrees of severity; some RVO are resolved without any treatment and others develop vision-threatening complications such as macular edema, combined retinal artery occlusion, vitreous hemorrhage, and glaucoma. Clinical conditions leading to RVO are still open to question. In this review, we discuss how to treat RVO in practice by presenting some RVO cases. We also deliver possible pathomechanisms of RVO through our clinical experience and animal experiments.
No takes yet. Share an insight, caveat, or question.
Teruyo Kida (2017) conducted a review in Retinal vein occlusion (RVO). Endothelin-1 and vein vasoactivity was evaluated. Endothelin-1 and vein vasoactivity are reviewed as possible pathomechanisms of retinal vein occlusion alongside practical clinical management cases, with no quantitative data reported.
Synapse has enriched 10 related papers. Consider them for comparative context: